REUTERS - Pfizer Inc said it reached a $2.15 billion settlement with Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd related to patent infringement on its acid-reflux drug Protonix.
Japan's Takeda Pharmaceutical Co Ltd , Pfizer's partner, will receive 36 percent or about $774 million from the settlement.
Israel-based Teva will pay $800 million in 2013 and the remaining $800 million by October 2014. India's Sun Pharma will make its entire payment of $550 million in 2013. (Reporting by Pallavi Ail in Bangalore,)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app